Navigation Links
DNA Damage and Repair - Quantification of Sub-Cellular Events Using Automated Confocal Imaging

Introduction

Oxidative stress, radiation and other external insults have been shown to damage DNA molecules in cells derived from organisms as diverse as bacteria, yeast, drosophila, rodents and man (Friedberg et al. 2005). The presence of DNA damage may lead to cell cycle checkpoint arrest to allow time for DNA repair processes to occur. If however, the system becomes overwhelmed or the DNA repair mechanisms are impaired, the cell either enters the apoptosis pathway or become cancerous due to the accumulation of mutations resulting from replication of damaged DNA. Therefore, a complete understanding of DNA repair mechanisms is of great interest in the study of cancer prevention and treatment. In addition, this process has been implicated in cellular senescence and aging (Sedelnikova et al. 2004). Following induction of DNA double strand breaks, the specialized histone protein H2AX becomes phosphorylated and rapidly (within minutes) accumulates at the sites of DNA damage forming distinct foci (Paull et al. 2000).

H2AX foci formation is followed by recruitment of many other proteins involved in the DNA repair process including the p53 binding protein 53BP1 (Schulz et al ., 2000). Over long time periods (hours), the number of foci declines with the progression of DNA repair. Detection and quantification of foci development as an indicator of DNA damage and repair is of great interest to groups investigating these pathways (Kim et al . 2005). The assay is generally performed using coverslips and chamber slides and imaged on fluorescence microscopes (Sedelnikova et al . 2004). The demands for high spatial resolution and sophisticated image analysis, however, have hindered the transfer of this assay into a multi-well plate format and thus into the drug screening arena. Our goal was to establish image acquisition and analysis methods allowing quantification of foci development both over time and with increasing concentrations of H2O2, a known inducer of DNA damage.

Methods

Cell Culture

HT1080 cells (ATCC, CCL-121, human fibrosarcoma derived cell line) were grown in 37C, 5%CO2 humidified incubators according to the suppliers protocol. Cells were seeded at 10,000 cell/well into 96 well plates (Cat. No. 353219) and incubated overnight. H2O2 (Sigma, H-1009) was used to initiate DNA double strand breaks. Immediately prior to the experiment, H2O2 was diluted in pre-warmed media and dose-response curves were obtained by serial dilution. Cells were exposed to chemical insult for 10 minutes at room temperature after which they were washed and replenished with fresh media. To allow for DNA repair processes to occur, the cells were returned to the incubator and left for 30, 90, or 180 minutes. In some experiments, cells were left to recover for 16 hours. At those time points, cells were fixed for 10 minutes with pre-warmed formaldehyde, 3.7% in phosphatebuffered saline (PBS), washed with PBS and permeabilized with ice-cold 90% methanol (10 minutes). Cells were washed twice with PBS and blocked using 1% BSA (in PBS) for 30 minutes. For the detection of phosphorylated H2AX, the mouse monoclonal anti-phospho serine 139 H2AX antibody (Chemicon, 05-636) at 2 μg/mL in 1% BSA block was used. 53BP1 was detected using the anti-53BP1 rabbit polyclonal antibody (Novus Biologicals, NB 100-304) diluted as described for H2AX.

After 1h at room temperature, the primary antibody was removed and cells were incubated with Tween 20 (0.05% in PBS, 10 minutes). Two PBS washes prepared the cells for the addition of the secondary antibodies, 5 μg/mL Alexa Fluor 555-conjugated anti-mouse IgG (Cat. No. A21424) for H2AX and 5 μg/mL Alexa Fluor 488-conjugated anti-rabbit IgG (Cat. No. A11034) for 53BP1, respectively. The DNA intercalating dye Hoechst 33342 (Invitrogen, H3570) was added at this point at 2 μg/mL and removed with the secondary antibodies after 1h at room temperature (light protected). Cells were washed as described above and wells replenished with 200 μL of PBS. Plates were sealed with adhesive foil and imaged on the BD Pathway Bioimager. Analysis of the image data was performed using BD IPLab for Pathway (Cat. No. 340989) and plotted using BD Image Data Explorer (Cat. No. 341039).

Results

Treatment of HT1080 cells with H2O2 rapidly induced the formation of phosphorylated H2AX and 53BP1 foci (Figure 1 ). There is a marked increase in the number and intensity of foci in H202 treated cells compared to control cells. The two foci shared a high degree of co-localization within nuclei as observed in the merged images.

Preliminary results had shown that the nuclear foci were not evenly distributed in the same focal plane ( Figure 2 ). We used the ability of the BD Pathway Bioimager to acquire 9 sections separated by 1.5 μm steps in confocal mode. To achieve the required spatial resolution, we used a 40 (NA 0.90) objective. Using the novel collapsed-stack acquisition feature, images were then automatically projected into a single focal plane with all objects appearing in focus.

This allowed segmentation and identification of objects within the nucleus using a customized image analysis routine written in BD IPLab for Pathway. The collapsed stack images were compared to images acquired in non-confocal mode ( Figure 2 shows part of an image containing a single nucleus). The analysis tool generated specific parameters such as foci count, foci area as percent nuclear area, average foci intensity and average foci size. On the cellular level, the response appeared highly heterogeneous and cells could be found that showed very few foci next to cells containing a large number of foci ( Figure 1 ). We therefore sampled on average 120 cells/well in a 33 montage. Data was imported into BD Image Data Explorer where dose-response curves and Z data were generated ( Figures 3 and 4 ).

Discussion

The ability to acquire confocal, collapsed stack images has allowed us to develop an automated assay relying on identification of small sub-nuclear features, namely foci of DNA damage and repair. The improved statistical performance of the assay in confocal, collapsed stack mode suggests that this assay indeed can be applied to a high-content screening environment.

We noted that even untreated cells contained some foci, suggesting that under basal conditions, some DNA doublestrand breaks are present and repair occurs. Phosphorylated H2AX accumulation was seen immediately after chemical treatment confirming the rapid time course of the activation and recruitment of this protein to the sites of DNA damage.
The subsequent accumulation of 53BP1 foci peaked between 30 and 90 minutes and is in agreement with published reports (Schultz et al . 2000). To our knowledge, the EC50 for H2O2-induced H2AX and 53BP1 foci formation has not been published and we believe that our assay can aid the characterization of other chemical agents and DNA repair proteins in a similar manner. The appearance of the 53BP1 foci in the same spatial location after 30 minutes confirms reports of rapid activation of the repair signaling cascade (Schultz et al . 2000)

Although we did not investigate the signaling properties between these two proteins, the assay is very suitable to investigate whether intermediate molecules are involved or whether 53BP1 is recruited by activated H2AX directly.

The comparatively straight-forward assay protocol using only 2 primary antibodies, 1 dye and a commercially available cell line allow this assay to be used in automated high-content screening applications where hands-off operation is required. The BD Pathway Bioimager with its confocal capability, white-light illumination and choice of 16 excitation filters allows development of multi-color assays and would even accommodate a 4th imaging channel. The complexity of change in the cellular phenotype in this assay mandate sophisticated and specialized image and data analysis algorithms. The combination of BD IPLab for Pathway and BD Image Data Explorer allows generation and analysis of high-content data in a drug screening environment.

References

1. Friedberg, E.C, Walker, G.C., Siede, et al . 2005 DNA Repair and Mutagenesis, ASM Press; 2nd edition ISBN : 1555813194

2. Kim, J-S, Krasieva, J_S, Kurumizaka, H, et al . 2005. Independent and sequential recruitment of NHEJ and HR factors to DNA damage sites in mammalian cells. JCB , 170, 341-347

3. Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., Bonner W.M..2000. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol. 10, 886-95.

4. Schultz, L.B, Chehab, N.H., Malikzay, A., Halazonetis, T.H., 2000. p53 Binding Protein 1 (53BP1) Is an Early Participant in the Cellular Response to DNA Double-Strand Breaks. JCB , 7, 1381-1390

5. Sedelnikova O.A., Horikawa I., Zimonjic D.B., Popescu N.C., Bonner W.M., Barrett J.C. 2004. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nature Cell Biology. 6, 168-70.


'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
2. Quantification made easy
3. Quantification of the Purinergic Receptor P2X3 using ICAT and Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer
4. Quantification of siRNA Silencing Efficiency Using the LightCycler System
5. Gene-Expression Analysis of TP, DPD, and TS Using the LightCycler mRNA Quantification KitsPLUS
6. Quantification of Nucleosomes in Serum by the Cell Death Detection ELISAplus
7. Real-Time Quantification of Genomic DNA Using DyNAzyme II DNA Polymerase and SYBR Green I Dye
8. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
9. Oil-Free PCR Using the Hot Top Assembly
10. Functional Cloning Using ViraPort Retroviral cDNA Expression Libraries
11. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
Post Your Comments:
(Date:2/27/2015)... Immunovaccine Inc. (“Immunovaccine”) (TSX: IMV), ... announced that the U.S. Food and Drug Administration ... and Phase I clinical trials of the DPX-Anthrax ... co-development agreement signed with Gilead Life Sciences. The ... the DPX-Survivac. , “We have been in talks ...
(Date:2/27/2015)... 27, 2015 FamilyFarms Group is pleased ... of State Line Farms, received the 2015 Tomorrow’s Top ... under the age of 35, who has demonstrated excellence ... honor to win the Tomorrow's Top Producer Horizon Award. ... the Top Producer Award and learning from their experiences. ...
(Date:2/26/2015)... NEW YORK , Feb. 26, 2015 ... commenced Factual Stock Report coverage on MabVax Therapeutics ... Inc. (MBVX) is a clinical stage biotechnology company focused ... address unmet medical needs in the treatment of cancer. ... products based on the protective immune responses generated by ...
(Date:2/26/2015)...   Synageva BioPharma Corp. (NASDAQ: ... products for rare disorders, today reported 2014 full ... key objectives, and financial guidance.  Synageva,s management team ... p.m. EST to review the financial results and ... today,s call by telephone, please dial (877) 445-4603 ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9
... 2007 Net Income of $13.1 Million, DUBLIN, Calif., ... pharmaceutical company dedicated to the discovery, rapid,development and commercialization ... financial results for the fourth,quarter and year ended December ... the 2007 fourth quarter of $5.1,million, or $0.09 per ...
... Osteotech, Inc.,(Nasdaq: OSTE ), a leader in ... announced today that Sam Owusu-Akyaw, Osteotech,s,President and Chief ... Orthopedics Conference at the Mission Bay Conference Center ... to present at 3:10 p.m.,Pacific Time on Tuesday, ...
... /PRNewswire-FirstCall/-- Dendreon Corporation (Nasdaq:,DNDN) announced the publication ... marker of antigen presenting cell activation" in ... supports the use of CD54 as a ... activation and validates,its utility as a potency ...
Cached Biology Technology:SuperGen Reports 2007 Fourth Quarter and Annual Financial Results 2SuperGen Reports 2007 Fourth Quarter and Annual Financial Results 3SuperGen Reports 2007 Fourth Quarter and Annual Financial Results 4SuperGen Reports 2007 Fourth Quarter and Annual Financial Results 5SuperGen Reports 2007 Fourth Quarter and Annual Financial Results 6SuperGen Reports 2007 Fourth Quarter and Annual Financial Results 7SuperGen Reports 2007 Fourth Quarter and Annual Financial Results 8SuperGen Reports 2007 Fourth Quarter and Annual Financial Results 9SuperGen Reports 2007 Fourth Quarter and Annual Financial Results 10SuperGen Reports 2007 Fourth Quarter and Annual Financial Results 11SuperGen Reports 2007 Fourth Quarter and Annual Financial Results 12Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation 2Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation 3
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to ... State of Washington,s Department of Licensing, in ... central issuance system for driver,s licenses and identification cards to ... and development will start in January 2015, with enrollment and ...
(Date:1/22/2015)... , Jan. 15, 2015  BellBrook Labs, a ... discovery, announced the launch of a TR-FRET (time ... company,s Transcreener UDP Assay, a high throughput screening ... new assay will allow for sensitive detection of ...
(Date:1/22/2015)... YORK , Jan. 21, 2015  Analyst Report Issued by ... Card Brands report showed that planet-wide, transactions at merchants on ... while the total number of credit, debit, and prepaid cards ... U.S. were victims of fraudulent card usage in 2012, and ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... Diseases from a mutation in one genome are ... between two genomes: the DNA in the nucleus and ... how such genomic disconnects cause disease. In a step ... University have traced one such incompatibility in fruit flies ...
... and the Federation of European Biochemical Societies (FEBS) announce Genevive ... as the winner of the 2013 FEBS | EMBO Women ... for her outstanding contributions to research in the area of ... and her active role in mentoring female scientists. The FEBS ...
... between two individuals in a population is crucial in ... New research has laid the foundation for a new ... for more targeted prevention strategies. By using novel ... Review Letters , outlines a predictive model of a ...
Cached Biology News:Mitochondrial mutations: When the cell's 2 genomes collide 2Mitochondrial mutations: When the cell's 2 genomes collide 3Geneviève Almouzni to receive the 2013 FEBS | EMBO Women in Science Award 2Geneviève Almouzni to receive the 2013 FEBS | EMBO Women in Science Award 3Can you predict how a disease will spread in a population? 2
Mouse monoclonal antibody to PAEP - progestagen-associated endometrial protein (placental protein 14, pregnancy-associated endometrial alpha-2-globulin, alpha uterine protein)...
Mouse polyclonal antibody to MCFD2 - multiple coagulation factor deficiency 2...
Volume adapter mounts on top of the 96 well FiltrEX filter plate and allows larger volumes (1mL) to be applied to each well in a filter plate. Adapters are nonsterile....
... Rabbit polyclonal to BMP2 ... factor beta (TGFB) superfamily. Bone morphogenic ... a candidate gene for the autosomal ... progressiva. Immunogen: Synthetic ...
Biology Products: